Bajaj Finserv Small Cap Fund
The scheme seeks to generate long term capital appreciation by investing in equity and equity related securities of small cap companies.
Growthvine rating: 2/5 — ranked #27 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹10.23 (as of 2026-10-23) |
|---|
| AUM | ₹2,762 Cr |
|---|
| Expense ratio | 1.69% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nimesh Chandan |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 6 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −16.98% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 122.0% of NIFTY Smallcap 250's upside and 96.9% of its downside.
Market cap allocation
| Large cap | 0.0% |
|---|
| Mid cap | 10.5% |
|---|
| Small cap | 89.5% |
|---|
Concentration
| Top 5 holdings | 16.0% |
|---|
| Top 10 holdings | 28.2% |
|---|
| Total holdings | 89 |
|---|
| Index overlap | 21.1% |
|---|
| Active share | 78.9% |
|---|
Top holdings
- Welspun Corp Limited — 4.0%
- RUBICON RESEARCH LIMITED — 3.5%
- Clearing Corporation of India Ltd — 3.3%
- CRISIL Ltd. — 2.9%
- Zydus Wellness Limited — 2.8%
- Schaeffler India Limited — 2.7%
- Timken India Ltd — 2.7%
- TD Power Systems Limited — 2.6%
- Great Eastern Shipping Co. Ltd. — 2.5%
- Sona BLW Precision Forgings Limited — 2.3%
Top sectors
- Industrial Products — 14.4%
- Pharma & Biotech — 10.6%
- Banking & Financial — 8.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 6.8% | Q2 | #10 of 34 |